JBIO (Jade Biosciences) Beginning Cash Position: $55.09 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

JBIO Jade Biosciences Inc JBIO
12 GF Score
Price $20.82
! 1 Warning Sign
View Full Analysis

What is Jade Biosciences Beginning Cash Position?

Jade Biosciences JBIO -2.16% 12 Beginning Cash Position is $55.09 Mil as of Jun. 2026. GuruFocus rates JBIO with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Jade Biosciences's Beginning Cash Position for the quarter that ended in Jun. 2026 was $55.09 Mil.

Jade Biosciences's quarterly Beginning Cash Position increased from Dec. 2025 ($50.09 Mil) to Mar. 2026 ($88.44 Mil) but then declined from Mar. 2026 ($88.44 Mil) to Jun. 2026 ($55.09 Mil).

Jade Biosciences's annual Beginning Cash Position stayed the same from . 20 ($0.00 Mil) to Dec. 2024 ($0.00 Mil) but then increased from Dec. 2024 ($0.00 Mil) to Dec. 2025 ($69.39 Mil).

Jade Biosciences Beginning Cash Position Related Terms

Jade Biosciences Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Jade Biosciences's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jade Biosciences Beginning Cash Position Chart

Jade Biosciences Annual Data
Trend Dec24 Dec25
Beginning Cash Position
0.00 69.39

Jade Biosciences Quarterly Data
Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beginning Cash Position Get a 7-Day Free Trial 49.93 220.94 50.09 88.44 55.09
JBIO
12GF Score
Jade Biosciences Inc JBIO
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jade Biosciences Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $55.09 Mil mean?
Jade Biosciences (JBIO) has a Beginning Cash Position of $55.09 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Jade Biosciences and its competitors.
Is Jade Biosciences' Beginning Cash Position too high?
Jade Biosciences' current Beginning Cash Position is $55.09 Mil. Overall, Jade Biosciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Jade Biosciences' Beginning Cash Position compare to NVAX and AVLN?
Jade Biosciences' Beginning Cash Position of $55.09 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Jade Biosciences and its competitors. Jade Biosciences's current Beginning Cash Position is $55.09 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jade Biosciences stock overvalued right now?
Jade Biosciences (JBIO) has a current Beginning Cash Position of $55.09 Mil. The current Beginning Cash Position is $55.09 Mil. Jade Biosciences' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Jade Biosciences (JBIO), the current Beginning Cash Position is $55.09 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jade Biosciences Business Description

Address 221 Crescent Street, Building 23, Suite 105, Waltham, MA, USA, 02453
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
12GF Score

Get the complete analysis for JBIO

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.82
Price